Ulrik Abildgaard

5.0k total citations · 1 hit paper
81 papers, 2.7k citations indexed

About

Ulrik Abildgaard is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulrik Abildgaard has authored 81 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 23 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulrik Abildgaard's work include Acute Myocardial Infarction Research (19 papers), Coronary Interventions and Diagnostics (15 papers) and Cardiac Imaging and Diagnostics (13 papers). Ulrik Abildgaard is often cited by papers focused on Acute Myocardial Infarction Research (19 papers), Coronary Interventions and Diagnostics (15 papers) and Cardiac Imaging and Diagnostics (13 papers). Ulrik Abildgaard collaborates with scholars based in Denmark, United States and Norway. Ulrik Abildgaard's co-authors include Gedske Daugaard, Henning Kelbæk, Henning Andersen, Per Thayssen, Leif Spange Mortensen, Leif Thuesen, Jan Kyst Madsen, Flemming Pedersen, Peer Grande and Torsten T. Nielsen and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Ulrik Abildgaard

80 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction

2003 916 citations Henning Andersen, Torsten T. Nielsen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrik Abildgaard Denmark	23	1.6k	938	628	306	277	81	2.7k
Philip A. Ludbrook United States	24	1.5k 0.9×	657 0.7×	876 1.4×	565 1.8×	148 0.5×	84	2.9k
M.J. Weston United Kingdom	28	632 0.4×	1.2k 1.3×	279 0.4×	526 1.7×	130 0.5×	122	3.0k
Gordon N. Olinger United States	27	1.6k 1.0×	1.2k 1.3×	350 0.6×	552 1.8×	513 1.9×	110	3.0k
Marco Tubaro Italy	27	2.4k 1.5×	1.1k 1.1×	797 1.3×	566 1.8×	57 0.2×	89	3.4k
Alan J. Tiefenbrunn United States	26	2.7k 1.6×	1.1k 1.1×	988 1.6×	438 1.4×	83 0.3×	53	3.6k
Mark A. Greenberg United States	22	3.1k 1.9×	2.1k 2.2×	1.7k 2.7×	760 2.5×	107 0.4×	54	4.4k
Gerard T. Sanders Netherlands	27	930 0.6×	534 0.6×	577 0.9×	310 1.0×	92 0.3×	75	2.4k
Harold L. Dauerman United States	34	2.5k 1.5×	1.8k 1.9×	808 1.3×	732 2.4×	64 0.2×	138	4.6k
Joaquín Alonso Spain	27	1.8k 1.1×	932 1.0×	687 1.1×	159 0.5×	204 0.7×	172	2.8k
Jung‐Won Suh South Korea	24	1.3k 0.8×	825 0.9×	421 0.7×	286 0.9×	66 0.2×	125	2.0k

Countries citing papers authored by Ulrik Abildgaard

Since Specialization

Citations

This map shows the geographic impact of Ulrik Abildgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrik Abildgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrik Abildgaard more than expected).

Fields of papers citing papers by Ulrik Abildgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrik Abildgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrik Abildgaard. The network helps show where Ulrik Abildgaard may publish in the future.

Co-authorship network of co-authors of Ulrik Abildgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrik Abildgaard. A scholar is included among the top collaborators of Ulrik Abildgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrik Abildgaard. Ulrik Abildgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alhakak, Alia Saed, Flemming Javier Olsen, Kristoffer Grundtvig Skaarup, et al.. (2023). Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City Heart Study. International Journal of Cardiology. 386. 141–148. 2 indexed citations

Alhakak, Alia Saed, Flemming Javier Olsen, Kristoffer Grundtvig Skaarup, et al.. (2023). Age- and sex-based normal reference ranges of the cardiac time intervals: the Copenhagen City Heart Study. Clinical Research in Cardiology. 114(4). 430–442. 3 indexed citations

Jeger, Raban, Matthias Pfisterer, D. Vogt, et al.. (2019). Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II. PLoS ONE. 14(1). e0210821–e0210821. 3 indexed citations

Kjøller‐Hansen, Lars, Henning Kelbæk, Evald Høj Christiansen, et al.. (2018). Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments. EuroIntervention. 14(7). 764–771. 6 indexed citations

Abildgaard, Ulrik, et al.. (2014). Association Between Endovascular Performance in a Simulated Setting and in the Catheterization Laboratory. Simulation in Healthcare The Journal of the Society for Simulation in Healthcare. 9(4). 241–248. 8 indexed citations

Mæng, Michael, Hans–Henrik Tilsted, Lisette Okkels Jensen, et al.. (2012). 3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents. JACC: Cardiovascular Interventions. 5(8). 812–818. 32 indexed citations

Iversen, Allan, Sune Pedersen, Rasmus Møgelvang, et al.. (2011). Impact of abciximab in diabetic patients with acute coronary syndrome who undergo percutaneous coronary intervention: results from a high-volume, single-center registry.. PubMed. 23(1). 21–6. 3 indexed citations

Nielsen, Peter Haubjerg, Christian Juhl Terkelsen, Torsten T. Nielsen, et al.. (2011). System Delay and Timing of Intervention in Acute Myocardial Infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] Trial). The American Journal of Cardiology. 108(6). 776–781. 36 indexed citations

Iversen, Allan, S. Galatius, Ulrik Abildgaard, et al.. (2011). Intracoronary Compared to Intravenous Abciximab in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention Reduces Mortality, Target Vessel Revascularization and Reinfarction after 1 Year. Cardiology. 120(1). 43–49. 7 indexed citations

10.

Sørensen, Rikke, Steen Z. Abildstrøm, Peter Weeke, et al.. (2010). Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study. BMC Cardiovascular Disorders. 10(1). 6–6. 8 indexed citations

11.

Pedersen, Sune, Søren Galatius, Peter Riis Hansen, et al.. (2009). Field Triage Reduces Treatment Delay and Improves Long-Term Clinical Outcome in Patients With Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 54(24). 2296–2302. 53 indexed citations

12.

Busk, Martin, Michael Mæng, Klaus Rasmussen, et al.. (2007). The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. European Heart Journal. 29(10). 1259–1266. 55 indexed citations

13.

Daugaard, Gedske, Ulrik Lassen, Peter Bie, et al.. (2004). Natriuretic Peptides in the Monitoring of Anthracycline Induced Reduction in Left Ventricular Ejection Fraction. European Journal of Heart Failure. 7(1). 87–93. 106 indexed citations

14.

Abildgaard, Ulrik. (2001). [Olav Egeberg--hereditary antithrombin deficiency and thrombophilia].. PubMed. 121(5). 604–5. 2 indexed citations

15.

Dahl, Tuva B., et al.. (1992). [A cerebrovascular unit. Experiences after 8-years of activity].. PubMed. 112(15). 1974–6. 1 indexed citations

16.

Daugaard, Gedske & Ulrik Abildgaard. (1992). Evaluation of nephrotoxicity secondary to cytostatic agents. Critical Reviews in Oncology/Hematology. 13(3). 215–240. 3 indexed citations

17.

Svendsen, Jesper Hastrup, Jan Aldershvile, Ulrik Abildgaard, & Ole Amtorp. (1989). Efficacy of Controlled-Release Isosorbide-5-Mononitrate as Adjunctive Treatment to β-Blocking Agents in Patients with Stable Angina Pectoris. Journal of Cardiovascular Pharmacology. 14(3). 358–363. 8 indexed citations

18.

Abildgaard, Ulrik, Ole Amtorp, Niels‐Henrik Holstein‐Rathlou, et al.. (1988). Effect of renal venous pressure elevation on tubular sodium and water reabsorption in the dog kidney. Acta Physiologica Scandinavica. 132(2). 135–142. 5 indexed citations

19.

Daugaard, Gedske, Ulrik Abildgaard, Niels‐Henrik Holstein‐Rathlou, et al.. (1988). Renal tubular function in patients treated with high-dose cisplatin. Clinical Pharmacology & Therapeutics. 44(2). 164–172. 112 indexed citations

20.

Ødegård, O.R. & Ulrik Abildgaard. (1977). Antithrombin III: Critical Review of Assay Methods. Significance of Variations in Health and Disease. Thrombosis and Haemostasis. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact